Loader

Pathways

PathWhiz ID Pathway Meta Data

PW176932

Pw176932 View Pathway
drug action

Bacampicillin Action Pathway

Escherichia coli
Bacampicillin is a s an ampicillin prodrug used to treat various susceptible bacterial infections in the body, such as respiratory infections and skin and subcutaneous tissue infections. Bacampicillin exhibits a bactericidal mode of action. It works by binding to and inhibiting bacterial penicillin-binding proteins (PBPs). Upon binding to PBPs, ertapenem inhibits bacterial cell wall synthesis by interfering with the lengthening and strengthening of the peptidoglycan portion of the cell wall, thereby inhibiting cell wall synthesis.

PW144481

Pw144481 View Pathway
drug action

Aztreonam Drug Metabolism Action Pathway

Homo sapiens

PW132363

Pw132363 View Pathway
metabolic

Aztreonam Drug Metabolism

Homo sapiens
Aztreonam is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Aztreonam passes through the liver and is then excreted from the body mainly through the kidney.

PW176960

Pw176960 View Pathway
drug action

Aztreonam Action Pathway

Escherichia coli
Aztreonam is a 1-β methyl-carbapenem that is structurally related to beta-lactam antibiotics.5 It was first authorized for use in the US in November 2001 and in Europe in April 2002. Shown to be effective against a wide range of Gram-positive and Gram-negative aerobic and anaerobic bacteria, ertapenem is used to treat various bacterial infections. Aztreonam exhibits a bactericidal mode of action. It works by binding to and inhibiting bacterial penicillin-binding proteins (PBPs).5 In Escherichia coli, it has a strong affinity toward PBPs 1a, 1b, 2, 3, 4 and 5 with preferential binding to PBPs 2 and 3.5 Upon binding to PBPs, ertapenem inhibits bacterial cell wall synthesis by interfering with the lengthening and strengthening of the peptidoglycan portion of the cell wall, thereby inhibiting cell wall synthesis.

PW145153

Pw145153 View Pathway
drug action

Azlocillin Drug Metabolism Action Pathway

Homo sapiens

PW127498

Pw127498 View Pathway
drug action

Azlocillin Action Pathway

Clostridium perfringens (strain 13 / Type A)
Azlocillin is a semisynthetic ampicillin-derived acylureido penicillin used for the treatment of bacterial infections caused by Pseudomonas aeruginosa, Escherichia coli, and Haemophilus influenzae. It inhibits specific penicillin-binding proteins located in the perisome of bacteria cells, which is the third and last stage of bacterial cell wall syntheis. This causes cell lysis and therefore the breakdown of the bacterial cell.

PW176321

Pw176321 View Pathway
metabolic

Azithromycin Predicted Metabolism Pathway

Homo sapiens
Metabolites of sildenafil are predicted with biotransformer.

PW144338

Pw144338 View Pathway
drug action

Azithromycin Drug Metabolism Action Pathway

Homo sapiens

PW126592

Pw126592 View Pathway
drug action

Azithromycin Action Pathway (New)

Homo sapiens
Azithromycin is a macrolide antibiotic used to treat a variety of bacterial infections. It is a broad-spectrum macrolide antibiotic with a long half-life and a high degree of tissue penetration. It is primarily used for the treatment of respiratory, enteric and genitourinary infections and may be used instead of other macrolides for some sexually transmitted and enteric infections. Like other macrolide antimicrobials, azithromycin binds to the 23S portion of the 50S bacterial ribosomal subunit. It inhibits bacterial protein synthesis by preventing the transit of aminoacyl-tRNA and the growing protein through the ribosome. Inhibition of protein synthesis kills the bacteria since essential proteins required for the bacteria to survive are not being produced.

PW128343

Pw128343 View Pathway
drug action

Azithromycin Action Pathway

Homo sapiens
Azithromycin is a broad-spectrum macrolide antibiotic with a long half-life and a high degree of tissue penetration. It is commonly administered via oral consumption and diffuses throughout the body. It is primarily used for the treatment of respiratory, enteric and genitourinary infections and may be used instead of other macrolides for some sexually transmitted and enteric infections. Like other macrolide antimicrobials, azithromycin binds to the 23S portion of the 50S bacterial ribosomal subunit. It inhibits bacterial protein synthesis by preventing the addition of aminoacyl-tRNA to the growing protein through the ribosome. Inhibition of protein synthesis leads to apoptosis of the bacteria since essential proteins required for the bacteria to survive are not being produced.